During a live event, Guru P. Sonpavde, MD discussed improvements to survival with cabozantinib plus nivolumab in metastatic ...

Dr. Hyung L. Kim discusses how the addition of cytoreductive nephrectomy to ICI therapy may affect survival and quality of ...

Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...

Recent therapeutic advances have changed the treatment landscape of metastatic renal cell carcinoma. Unfortunately, the seven agents now available are not based on biomarkers that would indicate ...

Purpose: The role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma (mRCC) is reviewed. Conclusion: The tyrosine kinase inhibitors sorafenib and sunitinib offer ...

Pal. Association between circulating B cell subtypes and treatment response in patients with metastatic renal cell carcinoma (mRCC) [abstract]. In: Proceedings of the American Association for Cancer ...

Possible complications of papillary renal cell carcinoma include: High blood pressure (hypertension) High red blood cell count High calcium levels in the blood Liver and spleen problems Metastasis ...

Patients were stratified by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk groups: favorable vs intermediate vs poor. The trial was designed to reach 80% power with 385 ...